-
This is part one of a two-part series on behavioral health issues. This month, we cover new research showing the link between depression interventions and productivity. Next month, we'll report on a growing trend toward integrating behavioral health and medical care.
-
In a move that runs counter to national public health guidelines and may contribute to the rise of drug-resistant pathogens, Pennsylvania has passed a state law that could lead to routinely culturing a wide variety of health care workers for methicillin-resistant Staphylococcus aureus (MRSA) and other multidrug-resistant organisms (MDROs).
-
A newly diagnosed diabetic, we'll call him Mr. Smith, called in to Capital District Physicians' Health Plan Health Coach Connection because his doctor had told him he needed to undergo gastric bypass surgery if he was going to live another 10 years. Smith was concerned and wanted to explore other options.
-
Legal risks and frequent abuse by employees are two problems faced by occupational health nurses (OHNs) responsible for overseeing administration of the Family and Medical Leave Act (FMLA).
-
For your smoking cessation programs to be successful, there are two things you should address, according to new research from Indiana University (IU).
-
Employees with chronic conditions that put them at risk for high health care costs but don't fall into traditional disease management programs are learning how to manage their conditions through the ComplexCare program from Health Management Corp.
-
-
The Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial began in 1986, enrolling 2,471 women with a positive first-degree family history of breast cancer.1 The treatment group received 20 mg tamoxifen daily for 8 years.
-
The author reviewed a year's worth of data from a busy hospital in France where manual rotation was liberally used. The procedure, which will be described below, was used in 796 patients, in whom 85 (9.7%) failed.
-
Germline mutations in BRCA1 or BRCA2 associated with the Hereditary Breast/Ovarian Cancer syndrome have an increased lifetime risk for breast (up to 85%) and ovarian (up to 46% BRCA1, up to 27% BRCA2) cancer.
